A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced esophageal carcinoma

被引：0
|
作者：
Chatterjee, A.
Biswas, J.
Bhattacharya, S.
Chatterjee, A. K.
Chakraborty, A.
Bhakta, R. S.
机构：
[1] Crit Canc Management Res Ctr & Clin, Kolkata, India
[2] Chittaranjan Natl Canc Inst, Kolkata, India
[3] RG Kar Med Coll & Hosp, Kolkata, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e13044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13044
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant camrelizumab plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial
    Gao, Jin
    Qian, Liting
    Zhou, Lingran
    Sun, Bin
    He, Jian
    Wang, Ru
    Zhang, Yangyang
    Yang, Liping
    Zhou, Yan
    Yang, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Single-arm Phase II cancer survival trial designs
    Wu, Jianrong
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2016, 26 (04) : 644 - 656
  • [23] Neoadjuvant pamiparib in patients with newly diagnosed advanced ovarian cancer: A single-arm, prospective phase II trial
    Liu, Jing
    Hu, Dan
    Li, Li
    Zang, Lele
    Zhu, Fei
    Zhu, Mingxuan
    Zhang, Huiqi
    Chang, Lele
    Xu, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Cadonilimab plus lenvatinib in patients with advanced endometrial cancer: A multicenter, single-arm, phase II trial.
    Lan, Chunyan
    Yang, Xielan
    Zhao, Jing
    Zheng, Min
    Yang, Fan
    Xie, Zhiwen
    Wu, Xiaoliu
    Yang, Hongying
    Wang, Wenyan
    Huang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Neoadjuvant nedaplatin and paclitaxel regimen with concurrent radiotherapy for esophageal squamous cell carcinoma: A single-arm phase II clinical trial
    Liu, T.
    Xiao, D.
    Li, Q.
    Chen, Y.
    Tian, J.
    Lin, Z.
    Ding, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S35 - S35
  • [26] Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial.
    Xu, Qin
    Chen, Chuanben
    Sun, Yang
    Huang, Zhangzhou
    Lin, Yibin
    Liu, Jing
    Li, Li
    Li, Zirong
    Pan, Junping
    Chen, Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [28] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Guozhen Yang
    Xiaodong Su
    Yuanheng Huang
    Guangyu Luo
    Zhiqiang Wang
    Peiqiang Cai
    Yating Zheng
    Ting Bei
    Mengli Huang
    Yuezong Bai
    Haoqiang He
    Jin Xiang
    Muyan Cai
    Jiudi Zhong
    Qiyu Guo
    Xu Zhang
    Journal of Translational Medicine, 21
  • [29] Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial
    Campbell, Matthew
    Balderrama-Brondani, Vania
    Jimenez, Camilo
    Tamsen, Gina
    Marcal, Leonardo P.
    Varghese, Jeena
    Shah, Amishi Y.
    Long, James P.
    Zhang, Miao
    Ochieng, Joshua
    Haymaker, Cara
    Habra, Mouhammed Amir
    LANCET ONCOLOGY, 2024, 25 (05): : 649 - 657
  • [30] Fruquintinib plus camrelizumab combined with paclitaxel liposome and nedaplatin as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II clinical trial
    Qiu, Tianzhu
    Mingjie, Lu
    Dong, Yuwen
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 445 - 445
12345